Results
1 -
10 of
92
(Click
here to explore results)
- Oxaliplatin and [Pt(R,R-DACH)(panobinostat-2H)] show nanomolar cytotoxicity towards diffuse intrinsic pontine glioma (DIPG). Marie H. C. Boulet, Laura K. Marsh, Alison Howarth, Alice Woolman, Nicola J. Farrer
, Dalton Trans.
, 2020
, 49
, 5703
- HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat. Kaja Zuwala, Anton A. A. Smith, Martin Tolstrup, Alexander N. Zelikin
, Chem. Sci.
, 2016
, 7
, 2353
- Histone deacetylase inhibitors for the treatment of cancer stem cells. M. Dvorakova, T. Vanek
, Med. Chem. Commun.
, 2016
, 7
, 2217
- Synthesis and antiproliferative assay of triazolyl-2,2-dimethyl-3-phenylpropanoates as potential HDAC inhibitors. Samir El-Rayes, Gomaa M. S., Abouelmagd A., Walid Fathalla, Ibrahim. A. I. Ali
, RSC Adv.
, 2019
, 9
, 13896
- Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies. Wei Zeng, Chi Han, Sarah Mohammed, Shanshan Li, Yixuan Song, Fengxia Sun, Yunfei Du
, RSC Med. Chem.
, 2024
, 15
, 788
- Nickel nanoparticles: a highly efficient and retrievable catalyst for the solventless Friedlander annulation of quinolines and their in silico molecular docking studies as histone deacetylase inhibitors. Gangadhara Angajala, Radhakrishnan Subashini
, RSC Adv.
, 2015
, 5
, 45599
- The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. Hai-Hao Han, Han-Min Wang, Paramesh Jangili, Mingle Li, Luling Wu, Yi Zang, Adam C. Sedgwick, Jia Li, Xiao-Peng He, Tony D. James, Jong Seung Kim
, Chem. Soc. Rev.
, 2023
, 52
, 879
- Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases. Thomas Beckers, Siavosh Mahboobi, Andreas Sellmer, Matthias Winkler, Emerich Eichhorn, Herwig Pongratz, Thomas Maier, Thomas Ciossek, Thomas Baer, Gerhard Kelter, Heinz-Herbert Fiebig, Mathias Schmidt
, Med. Chem. Commun.
, 2012
, 3
, 829
- Inhibition mechanism of SAHA in HDAC: a revisit. Jingwei Zhou, Ruibo Wu, Hai-Bin Luo
, Phys. Chem. Chem. Phys.
, 2015
, 17
, 29483
- Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks. Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, Alan P. Kumar, Markus Schweipert, Franz-Josef Meyer-Almes, Ramaa C S
, RSC Med. Chem.
, 2021
, 12
, 1540